These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3314453

  • 1. Two forms of vasoconstriction in systemic hypertension.
    Laragh JH.
    Am J Cardiol; 1987 Oct 30; 60(12):82G-93G. PubMed ID: 3314453
    [Abstract] [Full Text] [Related]

  • 2. Recognizing and treating two types of long-term vasoconstriction in hypertension.
    Laragh JH, Resnick LM.
    Kidney Int Suppl; 1988 Sep 30; 25():S162-74. PubMed ID: 3054233
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of diastolic hypertension.
    Laragh JH.
    Health Psychol; 1988 Sep 30; 7 Suppl():15-31. PubMed ID: 3072177
    [Abstract] [Full Text] [Related]

  • 4. Issues, goals, and guidelines in selecting first-line drug therapy for hypertension.
    Laragh JH.
    Hypertension; 1989 May 30; 13(5 Suppl):I103-12. PubMed ID: 2490815
    [Abstract] [Full Text] [Related]

  • 5. Clinical parameters of concern in the pathology and treatment of hypertension.
    Laragh JH.
    J Clin Hypertens; 1986 Sep 30; 2(3 Suppl):1S-11S. PubMed ID: 2947978
    [Abstract] [Full Text] [Related]

  • 6. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ, Laragh JH, Atlas SA, Case DB.
    J Hypertens Suppl; 1983 Oct 30; 1(1):77-84. PubMed ID: 6085835
    [Abstract] [Full Text] [Related]

  • 7. Lewis K. Dahl Memorial Lecture. The renin system and four lines fo hypertension research. Nephron heterogeneity, the calcium connection, the prorenin vasodilator limb, and plasma renin and heart attack.
    Laragh JH.
    Hypertension; 1992 Sep 30; 20(3):267-79. PubMed ID: 1516945
    [Abstract] [Full Text] [Related]

  • 8. The renin system and new understanding of the complications of hypertension and their treatment.
    Laragh JH.
    Arzneimittelforschung; 1993 Feb 30; 43(2A):247-54. PubMed ID: 8498972
    [Abstract] [Full Text] [Related]

  • 9. The renin system for understanding human hypertension: evidence for blood pressure control by a bipolar vasoconstriction-volume mechanism. Prorenin as a determinant of renin secretion.
    Laragh JH, Sealey JE, Atlas SA.
    Clin Exp Hypertens A; 1982 Feb 30; 4(11-12):2303-37. PubMed ID: 6756698
    [Abstract] [Full Text] [Related]

  • 10. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.
    Laragh JH, Sealey JE.
    Am J Hypertens; 2011 Nov 30; 24(11):1164-80. PubMed ID: 21938070
    [Abstract] [Full Text] [Related]

  • 11. Abnormal sodium metabolism and plasma renin activity (renal renin secretion) and the vasoconstriction volume hypothesis: implications for pathogenesis and treatment of hypertension and its vascular consequences (heart attack, stroke).
    Laragh JH, Sealey JE.
    Clin Chem; 1991 Oct 30; 37(10 Pt 2):1820-7. PubMed ID: 1914196
    [Abstract] [Full Text] [Related]

  • 12. A modern plan for treating hypertension.
    Laragh JH.
    Health Psychol; 1988 Oct 30; 7 Suppl():253-65. PubMed ID: 3072181
    [Abstract] [Full Text] [Related]

  • 13. The renin system for long-term control over vasoconstriction and sodium-volume homeostasis in the spectrum of hypertension: three new frontiers in research.
    Laragh JH.
    Clin Exp Hypertens A; 1983 Oct 30; 5(7-8):921-39. PubMed ID: 6357565
    [Abstract] [Full Text] [Related]

  • 14. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY, Thibonnier M, Corvol P, Menard J.
    J Cardiovasc Pharmacol; 1985 Oct 30; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [Abstract] [Full Text] [Related]

  • 15. Calcium antagonists as a new treatment modality in hypertension.
    Laragh JH.
    Angiology; 1988 Jan 30; 39(1 Pt 2):100-5. PubMed ID: 3277491
    [Abstract] [Full Text] [Related]

  • 16. Clinical evaluation and differential diagnosis of the individual hypertensive patient.
    Mueller FB, Laragh JH.
    Clin Chem; 1991 Oct 30; 37(10 Pt 2):1868-79. PubMed ID: 1914203
    [Abstract] [Full Text] [Related]

  • 17. Renal arteriolar injury by salt intake contributes to salt memory for the development of hypertension.
    Oguchi H, Sasamura H, Shinoda K, Morita S, Kono H, Nakagawa K, Ishiguro K, Hayashi K, Nakamura M, Azegami T, Oya M, Itoh H.
    Hypertension; 2014 Oct 30; 64(4):784-91. PubMed ID: 24980670
    [Abstract] [Full Text] [Related]

  • 18. Volume and vasoconstriction in experimental renovascular hypertension.
    Freeman RH, Davis JO, Seymour AA.
    Fed Proc; 1982 Jun 30; 41(8):2409-14. PubMed ID: 7044827
    [Abstract] [Full Text] [Related]

  • 19. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES, Fernandes LAB, Giollo-Júnior LT, Uyemura JRR, Matarucco CSS, Landim MIP, Cosenso-Martin LN, Tácito LHB, Moreno H, Vilela-Martin JF, Yugar-Toledo JC.
    Trials; 2018 Feb 12; 19(1):101. PubMed ID: 29433578
    [Abstract] [Full Text] [Related]

  • 20. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH, Case DB, Wallace JM, Keim H.
    Fed Proc; 1977 Apr 12; 36(5):1781-7. PubMed ID: 191300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.